Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma

[1]  T. Greiner,et al.  Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential , 2019, Insights into Imaging.

[2]  R. Nitrini,et al.  Diffuse large B-cell lymphoma of the central nervous system presenting as “lymphomatosis cerebri” and dementia in elderly man , 2019, Medicine.

[3]  Y. Li,et al.  Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson’s disease , 2018, International journal of molecular medicine.

[4]  C. Zhong,et al.  Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease. , 2019, Parkinsonism & related disorders.

[5]  Dennis W Dickson,et al.  Neuropathology of Parkinson disease. , 2018, Parkinsonism & related disorders.

[6]  W. Poewe,et al.  Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis , 2017, PloS one.

[7]  M. Shiroishi,et al.  Lymphomatosis cerebri: a rare variant of primary central nervous system lymphoma and MR imaging features , 2017, Cancer Imaging.

[8]  A. Dagher,et al.  Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.

[9]  M. Pfreundschuh,et al.  High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group , 2017, Leukemia.

[10]  J. Carnevale,et al.  The Challenge of Primary Central Nervous System Lymphoma. , 2016, Hematology/oncology clinics of North America.

[11]  A. Ferreri,et al.  The role of autologous stem cell transplantation in primary central nervous system lymphoma. , 2016, Blood.

[12]  Amos D. Korczyn,et al.  Vascular parkinsonism—characteristics, pathogenesis and treatment , 2015, Nature Reviews Neurology.

[13]  J. Finke,et al.  Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  Rakesh Kumar,et al.  Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings. , 2013, Revista espanola de medicina nuclear e imagen molecular.

[15]  J. Finke,et al.  Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  A. Spence,et al.  Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man , 2006, Journal of Neuro-Oncology.

[17]  J. Mazziotta,et al.  Lymphomatosis cerebri Presenting as a Rapidly Progressive Dementia: Clinical, Neuroimaging and Pathologic Findings , 1999, Dementia and Geriatric Cognitive Disorders.